ArticleInternational journal of surgery case reports2022
Leiomyosarcoma of the small bowel: A case report and literature review.
Article in International journal of surgery case reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 16 citations in OpenAlex.
- An unusual lead point: jejunal leiomyosarcoma causing jejuno-jejunal intussusception - a case report.International journal of surgery case reports · 2026Article
- Adult ileo-ileal intussusception from primary small bowel leiomyosarcoma: MRI diagnostic insights with corroborative histopathology.Radiology case reports · 2026Article
- A rare case report of small bowel leiomyosarcoma with literature review.Journal of surgical case reports · 2025Article
- Small bowel leiomyosarcoma: a case report and review of the literature.Journal of surgical case reports · 2025Article
- Primary Small Intestinal Leiomyosarcoma Presenting With Small Bowel Perforation: A Case Report.Cureus · 2024Article
- Article
- Unveiling a Jejunal Leiomyosarcoma Presenting as a Gastrointestinal Stromal Tumor: A Case Report.Cureus · 2024Article
- Leiomyosarcoma of the small bowel presenting as an acute small bowel obstruction.Journal of surgical case reports · 2024Article
- Current landscape of primary small bowel leiomyosarcoma: cases report and a decade of insights.Frontiers in oncology · 2024Article
- Inferior vena cava resection for a leiomyosarcoma: A case report.International journal of surgery case reports · 2023Article
- Gastrointestinal bleeding due to jejunal metastasis of pleomorphic lung carcinoma: a case report.Annals of medicine and surgery (2012) · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionMalignant tumors of the small bowel are rare. The jejunum, ileum, and duodenum represent the most common sites of intestinal leiomyosarcoma (LMS). Herein, we present a case of a 65-year-old patient having ileal LMS successfully treated with surgical resection. PRESENTATION OF CASE: A 65-year-old patient, with no comorbidities, presented with chronic and paroxysmal abdominal pain. Upper endoscopy and colonoscopy showed no abnormalities. Thoracoabdominal computed tomography (CT) revealed an ileal lobulated, heterogeneously enhancing solid mass measuring 6 cm. Laparotomy was performed. Findings showed a lobulated ileal mass. We made an enlarged ileal resection with end-to-end anastomosis. The postoperative course was uneventful. Histology and IHC stains concluded into ileal LMS. No relapse of the disease was noted during the 4-month follow-up. CLINICAL DISCUSSION: Ileal LMS is a rare tumor originating from the smooth muscle cells within the muscularis mucosa or muscularis propria. CT colonography (CTC) and magnetic resonance enterography (MRE) represent good options to aid the diagnosis. Histologically, LMS often has a comparable morphological appearance to GISTs. IHC is essential to differentiate those tumors. Surgery is the only curative treatment. The prognosis is poor knowing that those tumors are discovered at advanced stages.
conclusionIleal LMS is a rare tumor originating from the smooth muscle cells. It has a comparable morphological appearance to GISTs. Immunohistochemistry is essential to confirm the diagnosis. Surgery is the only curative treatment. The prognosis is poor.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.